Evaluation of the usage of incisional liposomal bupivacaine as a local anaesthetic for dogs undergoing limb amputation
Abstract Background Bupivacaine lioposomal suspension has recently emerged in the veterinary field for local analgesia. Objective To describe the extra‐label administration of bupivacaine liposomal suspension at the incision site of dogs undergoing limb amputation and characterize any complications....
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-07-01
|
| Series: | Veterinary Medicine and Science |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/vms3.1159 |
| _version_ | 1827897615521415168 |
|---|---|
| author | Ashley S Villatoro Holly A Phelps Justin B Ganjei |
| author_facet | Ashley S Villatoro Holly A Phelps Justin B Ganjei |
| author_sort | Ashley S Villatoro |
| collection | DOAJ |
| description | Abstract Background Bupivacaine lioposomal suspension has recently emerged in the veterinary field for local analgesia. Objective To describe the extra‐label administration of bupivacaine liposomal suspension at the incision site of dogs undergoing limb amputation and characterize any complications. Study Design Nonblinded retrospective study. Animals Client‐owned dogs undergoing limb amputation from 2016 to 2020. Methods Medical records of dogs undergoing limb amputation with concurrent use of long‐acting liposomal bupivacaine suspension were reviewed for incisional complications, adverse effects, hospitalization length, and time to alimentation. Data were compared to a control group (CG) of dogs who underwent a limb amputation procedure without concurrent use of liposomal bupivacaine suspension. Results Forty‐six dogs were included in the liposomal bupivacaine group (LBG) and 44 cases in the CG. The CG had 15 incidences of incisional complications (34%) compared to 6 within the LBG (13%). Four dogs required revisional surgery in the CG (9%) whereas none of the dogs required revisional surgery in the LBG. Time from surgery to discharge was statistically higher in the CG compared to the LBG (p = 0.025). First time to alimentation was statistically higher in the CG (p value = 0.0002). The total number of rechecks needed postoperatively revealed the CG having a statistically significant increase in recheck evaluations (p = 0.001). Conclusions Extra‐label administration of liposomal bupivacaine suspension was well‐tolerated in dogs undergoing limb amputation. Liposomal bupivacaine usage did not increase incisional complication rates and its use allowed for a quicker time to discharge. Clinical significance Surgeons should consider inclusion of extra‐label administration of liposomal bupivacaine in analgesic regimens for dogs undergoing limb amputation. |
| first_indexed | 2024-03-12T22:51:38Z |
| format | Article |
| id | doaj.art-0078c7c105c045c98488d281804702bd |
| institution | Directory Open Access Journal |
| issn | 2053-1095 |
| language | English |
| last_indexed | 2024-03-12T22:51:38Z |
| publishDate | 2023-07-01 |
| publisher | Wiley |
| record_format | Article |
| series | Veterinary Medicine and Science |
| spelling | doaj.art-0078c7c105c045c98488d281804702bd2023-07-20T08:09:46ZengWileyVeterinary Medicine and Science2053-10952023-07-01941547155210.1002/vms3.1159Evaluation of the usage of incisional liposomal bupivacaine as a local anaesthetic for dogs undergoing limb amputationAshley S Villatoro0Holly A Phelps1Justin B Ganjei2Veterinary Surgical Centers Vienna AustriaVeterinary Surgical Centers Leesburg Virginia USAVeterinary Referral Associates Vienna Virginia USAAbstract Background Bupivacaine lioposomal suspension has recently emerged in the veterinary field for local analgesia. Objective To describe the extra‐label administration of bupivacaine liposomal suspension at the incision site of dogs undergoing limb amputation and characterize any complications. Study Design Nonblinded retrospective study. Animals Client‐owned dogs undergoing limb amputation from 2016 to 2020. Methods Medical records of dogs undergoing limb amputation with concurrent use of long‐acting liposomal bupivacaine suspension were reviewed for incisional complications, adverse effects, hospitalization length, and time to alimentation. Data were compared to a control group (CG) of dogs who underwent a limb amputation procedure without concurrent use of liposomal bupivacaine suspension. Results Forty‐six dogs were included in the liposomal bupivacaine group (LBG) and 44 cases in the CG. The CG had 15 incidences of incisional complications (34%) compared to 6 within the LBG (13%). Four dogs required revisional surgery in the CG (9%) whereas none of the dogs required revisional surgery in the LBG. Time from surgery to discharge was statistically higher in the CG compared to the LBG (p = 0.025). First time to alimentation was statistically higher in the CG (p value = 0.0002). The total number of rechecks needed postoperatively revealed the CG having a statistically significant increase in recheck evaluations (p = 0.001). Conclusions Extra‐label administration of liposomal bupivacaine suspension was well‐tolerated in dogs undergoing limb amputation. Liposomal bupivacaine usage did not increase incisional complication rates and its use allowed for a quicker time to discharge. Clinical significance Surgeons should consider inclusion of extra‐label administration of liposomal bupivacaine in analgesic regimens for dogs undergoing limb amputation.https://doi.org/10.1002/vms3.1159control group (CG)liposomal bupivacaine group (LBG)liposomal bupivacaine suspension (LBS) |
| spellingShingle | Ashley S Villatoro Holly A Phelps Justin B Ganjei Evaluation of the usage of incisional liposomal bupivacaine as a local anaesthetic for dogs undergoing limb amputation Veterinary Medicine and Science control group (CG) liposomal bupivacaine group (LBG) liposomal bupivacaine suspension (LBS) |
| title | Evaluation of the usage of incisional liposomal bupivacaine as a local anaesthetic for dogs undergoing limb amputation |
| title_full | Evaluation of the usage of incisional liposomal bupivacaine as a local anaesthetic for dogs undergoing limb amputation |
| title_fullStr | Evaluation of the usage of incisional liposomal bupivacaine as a local anaesthetic for dogs undergoing limb amputation |
| title_full_unstemmed | Evaluation of the usage of incisional liposomal bupivacaine as a local anaesthetic for dogs undergoing limb amputation |
| title_short | Evaluation of the usage of incisional liposomal bupivacaine as a local anaesthetic for dogs undergoing limb amputation |
| title_sort | evaluation of the usage of incisional liposomal bupivacaine as a local anaesthetic for dogs undergoing limb amputation |
| topic | control group (CG) liposomal bupivacaine group (LBG) liposomal bupivacaine suspension (LBS) |
| url | https://doi.org/10.1002/vms3.1159 |
| work_keys_str_mv | AT ashleysvillatoro evaluationoftheusageofincisionalliposomalbupivacaineasalocalanaestheticfordogsundergoinglimbamputation AT hollyaphelps evaluationoftheusageofincisionalliposomalbupivacaineasalocalanaestheticfordogsundergoinglimbamputation AT justinbganjei evaluationoftheusageofincisionalliposomalbupivacaineasalocalanaestheticfordogsundergoinglimbamputation |